InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
Go back to InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes| InferX Corporation (NASDAQ: IFRX) | Delayed: 1.93 +0.03 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.90 | 52 Week High | $0.05 | |||
| Open | $1.84 | 52 Week Low | $0.00 | |||
| Day High | $1.98 | P/E | N/A | |||
| Day Low | $1.84 | EPS | $0.00 | |||
| Volume | 714,236 | |||||
